Herceptin Hylecta and Medroxyprogesterone

• Generic Name: hyaluronidase / trastuzumab
• Dosage Forms: injection, solution
• Other Brand Names: Herceptin Hylecta

Hyaluronidase is a genetically designed protein. Trastuzumab is a cancer medicine.

Herceptin Hylecta is a combination medicine used to treat certain types of breast cancer.

Herceptin Hylecta may also be used for purposes not listed in this medication guide.

• Generic Name: medroxyprogesterone
• Dosage Forms: n.a.
• Other Brand Names: Provera, Depo-Provera, Depo-subQ provera 104, Depo-Provera Contraceptive

Medroxyprogesterone is a progestin (a form of progesterone), a female hormone that helps regulate ovulation (the release of an egg from an ovary) and menstrual periods.

Medroxyprogesterone is used to treat conditions such as absent or irregular menstrual periods, or abnormal uterine bleeding. Medroxyprogesterone is also used to decrease the risk of endometrial hyperplasia (a condition that may lead to uterine cancer) while taking estrogens.

Medroxyprogesterone is also used to prevent overgrowth in the lining of the uterus in postmenopausal women who are receiving estrogen hormone replacement therapy.